携帯用酸素濃縮器の世界市場（2024年～2031年）

世界の携帯用酸素濃縮器の市場規模は、2023年に20億9,000万米ドルに達し、2031年には50億6,000万米ドルに達し、予測期間2024年～2031年にはCAGR11.8%で成長すると予測されています。

携帯用酸素濃縮器（POC）は、外出先で呼吸が必要な人に補助酸素を供給する小型・軽量の装置です。 これらの機器は、周囲の空気を取り込み、フィルターにかけ、鼻カニューレまたはマスクを通して濃縮酸素を供給します。POCは通常、バッテリー電源、AC電源、またはDC電源を利用するため、旅行を含むさまざまな環境で多用途に使用できます。

携帯用酸素濃縮器は、主にパルス投与システムを通じて酸素を供給し、吸入のたびに酸素を一気に放出しますが、モデルによっては連続流量のオプションもあります。航空会社によるPOCの機内使用の受け入れ拡大により、旅行中に酸素療法を必要とするユーザーの間でPOCの人気がさらに高まっています。

市場力学：

促進要因と抑制要因

携帯用酸素濃縮器の採用増加

携帯用酸素濃縮器（POC）市場は、これらのデバイスの採用が増加していることが大きな要因となって、大きな成長を遂げています。 この動向には、技術の進歩、患者数の増加、ヘルスケア力学の進化など、いくつかの重要な要因が寄与しています。世界人口の高齢化に伴い、加齢に関連した呼吸器疾患も増加しています。高齢者は特に、慢性閉塞性肺疾患（COPD）やその他の慢性肺疾患のような状態に陥りやすく、しばしば長期の酸素療法が必要となります。例えば、米国疾病予防管理センターによると、2021年には1,500万人以上のアメリカ人（6.4%）がCOPDと診断されたと報告しています。

酸素療法を必要とする可能性が高い高齢の患者は、日常生活や活動的なライフスタイルを維持できる携帯型のソリューションを好みます。例えば、2024年の米国国立衛生研究所によると、米国では毎年約150万人の患者が長期の酸素療法を受けています。この人口動態の変化はPOCの需要を大きく押し上げます。長期の酸素療法を必要とする患者の多くは、据置型システムやボンベよりも家庭用の携帯型濃縮器を好みます。POCにより、ユーザーは自宅内での移動性を維持し、屋外での活動を容易にすることができます。

最新の装置は、以前のモデルと比べて小型化、軽量化され、より使いやすくなっています。バッテリー技術の革新により、これらの濃縮器の携帯性が向上し、バッテリー寿命が長くなり、使用中の快適性が改善され、患者にとってより魅力的なものとなっています。

酸素流量の制限

携帯用酸素濃縮器（POC）市場は、主に慢性閉塞性肺疾患（COPD）、喘息、高齢化などによる呼吸器疾患の有病率の増加によって、着実な成長を遂げています。しかし、多くの機器が提供する酸素流量が限られているため、市場は課題に直面しています。

携帯用酸素濃縮器では一般に、連続フローで1～3リットル/分（LPM）の酸素流量を提供しており、パルスフロー設定ではより高い流量を利用できます。しかし、呼吸状態がより重篤な患者には、5LPM以上のような高流量が必要となる場合があります。この制限により、多くのPOCは進行期のCOPDや他の重篤な呼吸器疾患の患者に対する使い勝手が制限され、製造業者にとってターゲットとなる市場を狭めています。したがって、上記の要因は市場の成長を妨げる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 携帯用酸素濃縮器の採用増加
  • 抑制要因
    • 酸素流量制限
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 タイプ別

• 連続フロー
• パルス線量

第7章 用途別

• 喘息
• 慢性閉塞性肺疾患
• 呼吸窮迫症候群
• その他

第8章 エンドユーザー別

• 在宅ケア
• 旅行者
• 病院
• 外来手術センター
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Inogen, Inc.
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Koninklijke Philips N.V.
• Pure O2 Ltd
• Belluscura
• BPL Medical Technologies
• GCE Group
• Timago
• CAIRE Inc.
• ResMed
• Invacare Corporation

第12章 付録

The global portable oxygen concentrators market reached US$ 2.09 billion in 2023 and is expected to reach US$ 5.06 billion by 2031, growing at a CAGR of 11.8% during the forecast period 2024-2031.

Portable Oxygen Concentrators (POCs) are compact, lightweight devices that provide supplemental oxygen to individuals with respiratory needs while away from home. These machines draw in ambient air, filter it, and deliver concentrated oxygen through a nasal cannula or mask. POCs typically utilize battery power, AC electricity, or DC power, making them versatile for various settings, including travel.

Portable oxygen concentrators deliver oxygen primarily through pulse dose systems, releasing oxygen in bursts with each inhalation, although some models also offer continuous flow options. The growing acceptance of POCs by airlines for in-flight use has further enhanced their popularity among users who require oxygen therapy during travel.

Market Dynamics: Drivers & Restraints

Rising adoption of portable oxygen concentrators

The portable oxygen concentrators (POCs) market is experiencing significant growth, largely driven by the increasing adoption of these devices. Several key factors contribute to this trend, including advancements in technology, a growing patient population, and evolving healthcare dynamics. As the global population ages, there is a corresponding rise in age-related respiratory issues. Older adults are particularly vulnerable to conditions like chronic obstructive pulmonary disease (COPD) and other chronic lung diseases, which often necessitate long-term oxygen therapy. For instance, the Centers for Disease Control and Prevention stated that in 2021, more than 15 million Americans (6.4%) reported that they had been diagnosed with COPD.

Elderly patients, who are more likely to require oxygen therapy, prefer portable solutions that enable them to maintain their daily activities and active lifestyles. For instance, according to the National Institute of Health in 2024, each year, approximately 1.5 million patients in the USA receive long-term oxygen therapy. This demographic shift significantly boosts the demand for POCs. Many individuals requiring long-term oxygen therapy favor portable concentrators for home use over stationary systems or cylinders. POCs allow users to maintain mobility within their homes and facilitate outdoor activities.

Modern devices are now smaller, lighter, and more user-friendly compared to earlier models. Innovations in battery technology have enhanced the portability of these concentrators, resulting in longer battery life and improved comfort during use, making them more appealing to patients.

Limited oxygen flowrates

The portable oxygen concentrators (POCs) market is experiencing steady growth, primarily driven by the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and the aging population. However, the market faces challenges due to the limited oxygen flow rates offered by many devices.

Portable oxygen concentrators generally provide oxygen flow rates between 1 to 3 liters per minute (LPM) for continuous flow, with higher rates available for pulse flow settings. However, patients with more severe respiratory conditions may require higher flow rates, such as 5 LPM or more. This limitation restricts the usability of many POCs for individuals with advanced-stage COPD or other serious respiratory diseases, thereby narrowing the target market for manufacturers. Thus, the above factors could hinder the market growth.

Segment Analysis

The global Portable Oxygen Concentrators market is segmented based on product type, application, end-user and region.

Product Type:

Continuous flow oxygen concentrators segment is expected to dominate the portable oxygen concentrators market share

The continuous flow oxygen concentrators segment is expected to dominate the portable oxygen concentrators market. Continuous flow concentrators are particularly advantageous for patients with severe respiratory conditions, as they provide a steady supply of oxygen without the need for breath detection technology, making them more reliable for those requiring higher flow rates.

Additionally, advancements in technology have improved the efficiency and reliability of these devices, enhancing their appeal in both home healthcare settings and medical facilities. The cost-effectiveness of continuous flow concentrators, which tend to be cheaper than pulse flow models due to their simpler design, also contributes to their growing market dominance. For instance, the range of continuous flow portable oxygen concentrators begins from Philips SimplyGo, costing around ₹ 1.80 Lakh, to the top-end SeQual Eclipse, costing around ₹ 3.20 Lakh. This makes the consumers feel convenient over the other types.

Geographical Analysis

North America is expected to hold a significant position in the portable oxygen concentrators market share

North America holds a major portion of the portable oxygen concentrators market and is expected to hold a significant position in the portable oxygen concentrators market. This is due to the growing adoption of portable oxygen concentrators, the increasing number of product launches, and the rising prevalence of respiratory diseases.

The region is experiencing high rates of respiratory diseases such as asthma and COPD among others which increases the need for oxygen therapy. Increasing these conditions in the region increases the demand for these devices. For instance, according to the Asthma and Allergy Foundation of America, nearly 28 million people in the U.S. have asthma. This equals about 1 in 12 people. Nearly 23 million U.S. adults ages 18 and older have asthma. Asthma rates are highest in Black adults in the U.S.

The presence of a large number of key players in the region is also contributing to the growth of the region's market. Companies are introducing the latest portable oxygen concentrators in the region. For instance, in October 2024, Inogen, Inc. announced that it had commenced the U.S. market release of the Inogen Rove 4 Portable Oxygen Concentrator. With an additional, fourth flow setting delivering up to 840ml/min of medical grade oxygen, in a lightweight user-friendly design of less than 3 lbs1 and three battery configurations providing up to 5 hours and 45 minutes of operation2, the versatility of Rove 4 empowers patients with choices that may help them with normal activities of daily living.

Thus, rising technological advancements, increasing adoption and rising number of launches of the products in the region are expected to drive the region's market growth.

Asia-Pacific is growing at the fastest growing pace in the portable oxygen concentrators market

Asia-Pacific is at the fastest growing pace in portable oxygen concentrators. This is due to the rising number of launches of advanced oxygen concentrators and rising technological advancements in the region. There is a growing number of respiratory diseases among individuals in the region who are receiving oxygen therapies which is raising the demand for portable oxygen concentrators which makes the individuals carry them easily.

There is a growing adoption of portable oxygen concentrators among individuals in the region. With the rising number of Asthma patients, the need for these devices is rising. For instance, according to the report by the Global Asthma Network in 2022, among India's 1.36 billion people, about 35 million suffer from asthma.

Competitive Landscape

The major global players in the portable oxygen concentrators market include Inogen, Inc., Koninklijke Philips N.V., Pure O2 Ltd, Belluscura, BPL Medical Technologies, GCE Group, Timago, CAIRE Inc., ResMed, and Invacare Corporation among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global portable oxygen concentrators market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Application
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising adoption of portable oxygen concentrators
  • 4.1.2. Restraints
    • 4.1.2.1. Limited oxygen flowrates
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Continuous Flow*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Pulse Dose

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Asthma*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. COPD
• 7.4. Respiratory Distress Syndrome
• 7.5. Others

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Homecare*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Travelers
• 8.4. Hospitals
• 8.5. Ambulatory Surgical Centers
• 8.6. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. The U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Inogen, Inc.*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Koninklijke Philips N.V.
• 11.3. Pure O2 Ltd
• 11.4. Belluscura
• 11.5. BPL Medical Technologies
• 11.6. GCE Group
• 11.7. Timago
• 11.8. CAIRE Inc.
• 11.9. ResMed
• 11.10. Invacare Corporation

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us